ALEXION PHARMACEUTICALS, INC. - FORM 10-K - EX-32.2 - SECTION 906 CFO CERTIFICATION - February 23, 2010

Attached files

file filename
10-K - FORM 10-K - ALEXION PHARMACEUTICALS, INC.d10k.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - ALEXION PHARMACEUTICALS, INC.dex231.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - ALEXION PHARMACEUTICALS, INC.dex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - ALEXION PHARMACEUTICALS, INC.dex312.htm
EX-10.2 - AMENDMENT # 1 TO THE EMPLOYMENT AGMT - DR. LEONARD BELL - ALEXION PHARMACEUTICALS, INC.dex102.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - ALEXION PHARMACEUTICALS, INC.dex311.htm
EX-21.1 - SUBSIDIARIES - ALEXION PHARMACEUTICALS, INC.dex211.htm
EX-10.6 - AMENDMENT # 1 TO THE EMPLOYMENT AGMT - VIKAS SINHA - ALEXION PHARMACEUTICALS, INC.dex106.htm
EX-10.37 - AMENDED & RESTATED SECURITY AGREEMENT - ALEXION PHARMACEUTICALS, INC.dex1037.htm
EX-10.12 - FORM OF AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTS - ALEXION PHARMACEUTICALS, INC.dex1012.htm
EX-10.36 - AMENDED & RESTATED CREDIT AGREEMENT - ALEXION PHARMACEUTICALS, INC.dex1036.htm
EX-10.4 - AMENDMENT # 1 TO THE EMPLOYMENT AGMT - STEPHEN P. SQUINTO - ALEXION PHARMACEUTICALS, INC.dex104.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Alexion Pharmaceuticals, Inc. (the “Company”) for the year ended December 31, 2009 as filed with the Securities and Exchange Commission (the “Report”), I, Vikas Sinha, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: February 23, 2010

    

/s/    VIKAS SINHA        

    Senior Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

ALEXION PHARMACEUTICALS, INC. Reports